Group 1: Market Activity - Meituan-W recorded a net buy of HKD 5.55 million, with a trading volume of HKD 24.70 billion, reflecting a price increase of 3.0% [3] - Alibaba-W saw a net sell of HKD 0.39 million, with a trading volume of HKD 23.71 billion, and a price increase of 0.6% [3] - Tencent Holdings experienced a net sell of HKD 14.36 million, with a trading volume of HKD 17.96 billion, and a price increase of 1.4% [3] - Xinda Biologics had a significant price increase of 14.1%, with a net buy of HKD 2.97 million and a trading volume of HKD 22.00 billion [3] Group 2: Fund Flows - Southbound funds have continuously net bought Meituan for 13 days, totaling HKD 144.1059 million, and have net bought Xinda Biologics for 4 days, totaling HKD 22.5265 million [4] - Southbound funds have net bought Alibaba for 3 days, totaling HKD 16.494 million, while they have net sold Tencent for 4 days, totaling HKD 30.6792 million [4] Group 3: Company Developments - Xinda Biologics reported positive clinical trial results for its first-in-class PD-1/IL-2α-bias dual-specific antibody IBI363 for advanced non-small cell lung cancer at the 2025 ASCO annual meeting [6] - BYD plans to launch a low-cost micro electric vehicle in Japan next year, targeting the USD 18 billion microcar market, and reported a 15.3% year-on-year increase in May's new energy vehicle sales [7] - Xiaomi Group faced a net sell of HKD 13.75 million, with a focus on its upcoming product launch and a gradual reduction in losses from its automotive business, expecting profitability in the third to fourth quarter of this year [7]

Group 1: Market Overview - The Hong Kong stock market saw a net inflow of 35.16 billion HKD from Northbound trading on June 4, with 27.74 billion HKD from the Shanghai Stock Connect and 7.42 billion HKD from the Shenzhen Stock Connect [1] - The most bought stocks included Meituan-W (03690), Alibaba-W (09988), and BYD Company (01211), while the most sold stocks were Tencent (00700), Xiaomi Group-W (01810), and SMIC (00981) [1] Group 2: Stock Performance - Meituan-W (03690) recorded a net inflow of 14.13 billion HKD, driven by significant growth in new customers and sales during its recent promotional campaign [6] - Alibaba-W (09988) saw a net inflow of 6.19 billion HKD, with expectations of a 2 trillion RMB market opportunity in instant shopping by 2030 [6] - BYD Company (01211) had a net inflow of 3.93 billion HKD, planning to launch a low-cost micro electric vehicle in Japan and reporting a 15.3% year-on-year increase in May's new energy vehicle sales [7] - Sinopharm Group (01801) received a net inflow of 3.67 billion HKD, presenting promising clinical trial data for its innovative cancer treatment [7] - CSPC Pharmaceutical Group (01093) attracted a net inflow of 3.3 billion HKD, negotiating potential licensing deals worth up to 5 billion USD [8] - Xiaomi Group-W (01810) faced a net outflow of 13.75 billion HKD, with ongoing discussions about its automotive business profitability [8] - Tencent (00700) experienced a net outflow of 14.35 billion HKD, with management indicating that AI product monetization will take several quarters [9]

Core Viewpoint - BYD plans to launch a low-cost micro electric vehicle in Japan next year, targeting the $18 billion microcar market [1] Group 1: Company Performance - In May, BYD's new energy vehicle sales reached 382,500 units, representing a year-on-year increase of 15.3% [1] - Overseas sales of passenger cars and pickups amounted to 88,640 units, showing a significant year-on-year growth of 133.6% [1] Group 2: Market Outlook - Multiple brokerages anticipate that BYD's export growth will continue at a high rate through 2025, driven by an expanding overseas vehicle lineup, improved production capacity, and enhanced distribution channels [1]